Cargando…

Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study

BACKGROUND: Fibroblast growth factor 23 (FGF23), a phosphate-regulating hormone that increases early in the course of chronic kidney disease (CKD), is associated with disease progression in patients with established CKD. Here we aimed to investigate the association between plasma FGF23 and new-onset...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Jong, Maarten A, Eisenga, Michele F, van Ballegooijen, Adriana J, Beulens, Joline W J, Vervloet, Marc G, Navis, Gerjan, Gansevoort, Ron T, Bakker, Stephan J L, De Borst, Martin H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	ORIGINAL ARTICLES
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771975/ https://www.ncbi.nlm.nih.gov/pubmed/32124925 http://dx.doi.org/10.1093/ndt/gfz266

Ejemplares similares

Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
por: Abbasi, Ali, et al.
Publicado: (2014)

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study
por: Binnenmars, S. Heleen, et al.
Publicado: (2022)

Prevalence and Effects of Functional Vitamin K Insufficiency: The PREVEND Study
por: Riphagen, Ineke J., et al.
Publicado: (2017)

Urinary Potassium Excretion, Fibroblast Growth Factor 23, and Incident Hypertension in the General Population-Based PREVEND Cohort
por: Yeung, Stanley M. H., et al.
Publicado: (2021)

Body fat estimates from bioelectrical impedance equations in cardiovascular risk assessment: The PREVEND cohort study
por: Byambasukh, Oyuntugs, et al.
Publicado: (2019)

Separating the effects of 24-hour urinary chloride and sodium excretion on blood pressure and risk of hypertension: Results from PREVEND
por: van der Leeuw, Joep, et al.
Publicado: (2020)

Predictors of Progression in Albuminuria in the General Population: Results from the PREVEND Cohort
por: Scheven, Lieneke, et al.
Publicado: (2013)

Combined low vitamin D and K status amplifies mortality risk: a prospective study
por: van Ballegooijen, Adriana J., et al.
Publicado: (2020)

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort
por: Van Deutekom, Colinda, et al.
Publicado: (2023)

Response of fibroblast growth factor 23 to volume interventions in arterial hypertension and diabetic nephropathy
por: Humalda, Jelmer K., et al.
Publicado: (2016)

Urinary albumin excretion and cancer risk: the PREVEND cohort study
por: Luo, Li, et al.
Publicado: (2023)

Reversal Of Arterial Disease by modulating Magnesium and Phosphate (ROADMAP-study): rationale and design of a randomized controlled trial assessing the effects of magnesium citrate supplementation and phosphate-binding therapy on arterial stiffness in moderate chronic kidney disease
por: Vermeulen, Emma A., et al.
Publicado: (2022)

High selenium levels associate with reduced risk of mortality and new‐onset heart failure: data from PREVEND
por: Al‐Mubarak, Ali A., et al.
Publicado: (2022)

Heart Rate Variability and Its Relation to Chronic Kidney Disease: Results From the PREVEND Study
por: Thio, Christian H.L., et al.
Publicado: (2018)

Erythropoietin, Fibroblast Growth Factor 23, and Death After Kidney Transplantation
por: Eisenga, Michele F., et al.
Publicado: (2020)

Genomic Damage in Endstage Renal Disease—Contribution of Uremic Toxins
por: Schupp, Nicole, et al.
Publicado: (2010)

Plasma potassium, diuretic use and risk of developing chronic kidney disease in a predominantly White population
por: Kieneker, Lyanne M., et al.
Publicado: (2017)

Self‐Reported Smoking, Urine Cotinine, and Risk of Cardiovascular Disease: Findings From the PREVEND (Prevention of Renal and Vascular End‐Stage Disease) Prospective Cohort Study
por: Kunutsor, Setor K., et al.
Publicado: (2018)

Relative fat mass, a new index of adiposity, is strongly associated with incident heart failure: data from PREVEND
por: Suthahar, Navin, et al.
Publicado: (2022)

Clustering of cardiovascular and renal comorbidities and risk of incident atrial fibrillation in the community-based PREVEND cohort
por: Van Deutekom, C, et al.
Publicado: (2023)

Vitamin B6, Inflammation, and Cardiovascular Outcome in a Population-Based Cohort: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) Study
por: Minović, Isidor, et al.
Publicado: (2020)

Indomethacin Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in Chronic Kidney Disease Patients: A Post-Hoc Analysis
por: de Borst, Martin H., et al.
Publicado: (2012)

Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study
por: Zwartkruis, Victor W, et al.
Publicado: (2021)

Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial
por: de Borst, Martin H., et al.
Publicado: (2017)

Characterization of gut-homing molecules in non-endstage livers of patients with primary sclerosing cholangitis and inflammatory bowel disease
por: de Krijger, Manon, et al.
Publicado: (2020)

Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study
por: Eisenga, Michele F., et al.
Publicado: (2019)

Plasma ApoE elevations are associated with NAFLD: The PREVEND Study
por: van den Berg, Eline H., et al.
Publicado: (2019)

Circulating FGF21 Concentration, Fasting Plasma Glucose, and the Risk of Type 2 Diabetes: Results From the PREVEND Study
por: Post, Adrian, et al.
Publicado: (2022)

Peroxiredoxin 4, A Novel Circulating Biomarker for Oxidative Stress and the Risk of Incident Cardiovascular Disease and All-Cause Mortality
por: Abbasi, Ali, et al.
Publicado: (2012)

GlycA, a novel pro‐inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta‐analysis
por: Gruppen, E. G., et al.
Publicado: (2019)

Effect of 6-Month Vitamin D Supplementation on Plasma Matrix Gla Protein in Older Adults
por: van Ballegooijen, Adriana J., et al.
Publicado: (2019)

Magnesium intake and vascular structure and function: the Hoorn Study
por: Vermeulen, Emma A., et al.
Publicado: (2021)

Lipoprotein particle sizes and incident type 2 diabetes: the PREVEND cohort study
por: Sokooti, Sara, et al.
Publicado: (2021)

HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study
por: Sokooti, Sara, et al.
Publicado: (2021)

Phosphate and fibroblast growth factor 23 in diabetes
por: van der Vaart, Amarens, et al.
Publicado: (2021)

Soluble Vascular Cell Adhesion Molecules May be Protective of Future Cardiovascular Disease Risk: Findings from the PREVEND Prospective Cohort Study
por: Kunutsor, Setor K., et al.
Publicado: (2017)

Plasma creatine concentration is associated with incident hypertension in a cohort enriched for the presence of high urinary albumin concentration: the Prevention of Renal and Vascular Endstage Disease study
por: Post, Adrian, et al.
Publicado: (2022)

Relation between Red Cell Distribution Width and Fibroblast Growth Factor 23 Cleaving in Patients with Chronic Kidney Disease and Heart Failure
por: van Breda, Fenna, et al.
Publicado: (2015)

Liver Function Tests and Risk Prediction of Incident Type 2 Diabetes: Evaluation in Two Independent Cohorts
por: Abbasi, Ali, et al.
Publicado: (2012)

Urinary potassium excretion and mortality risk in community-dwelling individuals with and without obesity
por: Yeung, Stanley M H, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_voqk4ck0jdbbn1q8pq4g3865hp